Bangalore- Indranil Sen, Chief Financial Officer (CFO) of Bengaluru-based Indian biopharmaceutical company Biocon, has resigned from his post effective from March 16, 2024.Indranil obtained his Chartered Accountant qualification from the Institute of Chartered Accountants of India, New Delhi.He joined Biocon 2014, after which he held various positions in the finance department. Mr Sen...
Bangalore- Indranil Sen, Chief Financial Officer (CFO) of Bengaluru-based Indian biopharmaceutical company Biocon, has resigned from his post effective from March 16, 2024.
Indranil obtained his Chartered Accountant qualification from the Institute of Chartered Accountants of India, New Delhi.
He joined Biocon 2014, after which he held various positions in the finance department. Mr Sen was appointed Chief Financial Officer (CFO) in April 2021 after Anupam Jindal stepped down from the post of CFO.
Indranil possesses more than two decades of extensive expertise in financial planning, treasury management, taxation, and financial reporting. His professional journey commenced in statutory audit, where he contributed to renowned firms such as B S R & Co. (the Indian division of KPMG) in Kolkata and S R Batliboi & Co. (the Indian branch of Ernst & Young) in Bengaluru.
Before joining Biocon, he held the position of Director of Finance at Symphony Teleca, a well-known multinational IT corporation headquartered in the United States.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd